DNMT3A and acute lymphoblastic leukemia: These results demonstrated that sgRNA mediated Cas9 knock-out of DNMT3A can causes Reh and 697 cell lines to be resistant to DNR, implying that DNMT3A expression plays an important role in the sensitivity of B-ALL leukemic cells to chemotherapeutic drugs such as DNR.